Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challengePUANGPETCH, Apichaya; ANDERSON, Robert; HUANG, Yan Y et al.Vaccine. 2014, Vol 32, Num 45, pp 5983-5988, issn 0264-410X, 6 p.Article

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccineCOOPER, C. L; DAVIS, H. L; CAMERON, D. W et al.Vaccine. 2004, Vol 22, Num 23-24, pp 3136-3143, issn 0264-410X, 8 p.Article

Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotidesZEUNER, R. A; KLINMAN, D. M; ILLEI, G et al.Rheumatology (Oxford. Print). 2003, Vol 42, Num 4, pp 563-569, issn 1462-0324, 7 p.Article

Improved systemic pharmacokinetics, biodistribution, and antitumor activity of CpG oligodeoxynucleotides complexed to endogenous antibodies in vivoPALMA, Enzo; CHO, Moo J.Journal of controlled release. 2007, Vol 120, Num 1-2, pp 95-103, issn 0168-3659, 9 p.Article

Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responsesROUX, Stephan; BERNAT, Claire; AL-SAKERE, Bassim et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 9, pp 1291-1300, issn 0340-7004, 10 p.Article

Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated microporesHESSENBERGER, Michael; WEISS, Richard; WEINBERGER, Esther E et al.Vaccine. 2013, Vol 31, Num 34, pp 3427-3434, issn 0264-410X, 8 p.Conference Paper

Oral immunization with Porphyromonas gingivalis outer membrane protein and CpG oligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunityLIU, C; HASHIZUME, T; KURITA-OCHIAI, T et al.Molecular oral microbiology (Print). 2010, Vol 25, Num 3, pp 178-189, issn 2041-1006, 12 p.Article

Response of nitric oxide production to CpG oligodeoxynucleotides in turkey and chicken peripheral blood monocytesHAIQI HE; GENOVESE, Kenneth J; LOWRY, Virginia K et al.FEMS immunology and medical microbiology. 2006, Vol 48, Num 1, pp 99-106, issn 0928-8244, 8 p.Article

Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in miceYING LIU; XING LUO; CHUNTING YANG et al.Vaccine. 2011, Vol 29, Num 34, pp 5778-5784, issn 0264-410X, 7 p.Article

Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2KWANT, Amanda; ROSENTHAL, Kenneth L.Vaccine. 2004, Vol 22, Num 23-24, pp 3098-3104, issn 0264-410X, 7 p.Article

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticlesBORGES, Olga; CORDEIRO-DA-SILVA, Anabela; TAVARES, Joana et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 69, Num 2, pp 405-416, issn 0939-6411, 12 p.Article

Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathwayHUANG, Wan-Ting; WENG, Shao-Wen; HUANG, Chao-Cheng et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2012, Vol 120, Num 11, pp 872-881, issn 0903-4641, 10 p.Article

Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvantKODAMA, Satoru; ABE, Nobuyuki; HIRANO, Takashi et al.The Laryngoscope. 2006, Vol 116, Num 2, pp 331-335, issn 0023-852X, 5 p.Article

Structure-activity relationship of a guanine-free oligodeoxynucleotide as immunopotent inhibitorZHANG, Yong-Sheng; WU, Xiu-Li; YING WANG et al.International immunopharmacology (Print). 2012, Vol 13, Num 4, pp 446-453, issn 1567-5769, 8 p.Article

The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODNRANEY, Sameersingh G; WILSON, Kaley D; SEKIROV, Laura et al.Journal of drug targeting. 2008, Vol 16, Num 7-8, pp 564-577, issn 1061-186X, 14 p.Article

Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cellsBAUMGAERTNER, Petra; JANDUS, Camilla; RUFER, Nathalie et al.International journal of cancer (Print). 2012, Vol 130, Num 11, pp 2607-2617, issn 0020-7136, 11 p.Article

TLR9 Signaling Failure Renders Peyer's Patch Regulatory B Cells Unresponsive to Stimulation with CpG OligodeoxynucleotidesBOOTH, Jayaum S; ARSENAULT, Ryan; NAPPER, Scott et al.Journal of innate immunity (Print). 2010, Vol 2, Num 5, pp 483-494, issn 1662-811X, 12 p.Article

Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotidesBRIGNOLE, Chiara; MARIMPIETRI, Danilo; PISTOIA, Vito et al.Journal of controlled release. 2009, Vol 138, Num 2, pp 122-127, issn 0168-3659, 6 p.Article

CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirusCHUNTING YANG; HUIYING SHI; JUN ZHOU et al.Vaccine. 2009, Vol 27, Num 47, pp 6558-6563, issn 0264-410X, 6 p.Article

Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigenBORGES, Olga; SILVA, Marta; DE SOUSA, Adriano et al.International immunopharmacology (Print). 2008, Vol 8, Num 13-14, pp 1773-1780, issn 1567-5769, 8 p.Article

Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenograftsBALSARI, A; TORTORETO, M; BESUSSO, D et al.European journal of cancer (1990). 2004, Vol 40, Num 8, pp 1275-1281, issn 0959-8049, 7 p.Article

The expression of prophenoloxidase mRNA in red swamp crayfish, Procambarus clarkii, when it was challengedYANHE LI; WEI DENG; KELI YANG et al.Genomics (San Diego, Calif.). 2012, Vol 99, Num 6, pp 355-360, issn 0888-7543, 6 p.Article

Evaluation of the immune response following a short oral vaccination schedule with hepatitis b antigen encapsulated into alginate-coated chitosan nanoparticlesBORGES, Olga; TAUARES, Joana; DE SOUSA, Adriano et al.European journal of pharmaceutical sciences. 2007, Vol 32, Num 4-5, pp 278-290, issn 0928-0987, 13 p.Article

Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticlesWILSON, Kaley D; RANEY, Sameersingh G; SEKIROV, Laura et al.International immunopharmacology. 2007, Vol 7, Num 8, pp 1064-1075, issn 1567-5769, 12 p.Article

CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitroMATSUMOTO, Kenji; TERAKAWA, Maki; FUKUDA, Shuhei et al.International archives of allergy and immunology. 2006, Vol 140, pp 42-50, issn 1018-2438, 9 p., SUP1Conference Paper